Quest Diagnostics Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.40B | $7.21B | $7.49B | $7.44B | $7.15B | $7.38B | $7.39B | $7.26B |
| Diagnostic Information Services | — | — | — | — | — | — | — | — |
| Diagnostic Solutions | — | — | — | — | — | — | — | — |
| Cost of Revenue | $4.72B | $4.62B | $4.66B | $4.64B | $4.33B | $4.37B | $4.36B | $4.28B |
| Gross Profit | $2.68B | $2.90B | $2.84B | $2.80B | $2.82B | $3.02B | $3.03B | $3.05B |
| Gross Margin | 36.2% | 40.2% | 37.8% | 37.6% | 39.5% | 40.9% | 41.0% | 42.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.44B | $1.38B | $1.68B | $1.73B | $1.70B | $1.75B | $1.74B | $1.66B |
| Operating Income | $1.17B | $1.28B | $1.40B | $983.0M | $1.48B | $1.20B | $987.0M | $1.28B |
| Operating Margin | 15.7% | 17.7% | 18.7% | 13.2% | 20.6% | 16.3% | 13.4% | 17.7% |
| Interest Expense | $153.0M | $144.0M | $154.0M | $167.0M | — | — | $173.3M | $147.5M |
| Pretax Income | $1.03B | $1.09B | $1.10B | $823.0M | $1.32B | — | $856.2M | $1.18B |
| Income Tax Expense | $241.0M | $429.0M | $373.0M | $262.0M | $500.0M | $402.0M | $355.0M | $430.1M |
| Net Income | $772.0M | $645.0M | $709.0M | $556.0M | $849.0M | $556.0M | $471.0M | $720.9M |
| Net Margin | 10.4% | 8.9% | 9.5% | 7.5% | 11.9% | 7.5% | 6.4% | 9.9% |
| EPS (Basic) | $5.63 | $4.58 | $4.92 | $3.83 | $5.58 | $3.49 | $2.95 | $4.08 |
| EPS (Diluted) | $5.50 | $4.51 | $4.87 | $3.81 | $5.54 | $3.46 | $2.92 | $4.05 |
| Shares Outstanding (Basic) | 137.0M | 140.0M | 144.0M | 145.0M | 152.0M | 159.0M | 159.0M | 175.7M |
| Shares Outstanding (Diluted) | 140.0M | 142.0M | 145.0M | 145.0M | 153.0M | 160.0M | 160.0M | 177.3M |
| Dividends Per Share | $1.80 | $1.65 | $1.52 | $1.32 | $1.20 | $0.81 | $0.47 | $0.40 |